Table 3.
Category | Adverse event | All grades Number of patients (%) |
Grades 3–4 Number of patients (%) |
---|---|---|---|
Cardiac | Prolonged QTc | 8 (40) | 0 (0) |
Gastrointestinal | Anorexia | 12 (60) | 0 (0) |
Abdominal pain | 4 (20) | 0 (0) | |
Diarrhea | 16 (80) | 3 (15) | |
Mucositis | 4 (20) | 1 (5) | |
Nausea | 16 (80) | 1 (5) | |
Vomiting | 12 (60) | 1 (5) | |
General | Fatigue | 10 (50) | 3 (15) |
Hematologic | White blood cell decreased | 4 (20) | 4 (20) |
Investigations | Weight loss | 9 (45) | 0 (0) |
Metabolic | Dehydration | 9 (45) | 1 (5) |
Musculoskeletal | Generalized muscle weakness | 6 (30) | 0 (0) |
Neurologic | Dizziness | 4 (20) | 0 (0) |
Dysgeusia | 10 (50) | 0 (0) | |
Vascular | Flushing | 4 (20) | 0 (0) |
Includes toxicities with at least 20% incidence